Identifying factors that link impaired GLP-1 secretion to obesity and inflammation can help to generate a better understanding of why the comorbid occurrence of these conditions contributes to progressive worsening of T2DM and other related diseases, and may be key to disrupting vicious cycles between these diseases. This evidence concerns the gene GCG and type 2 diabetes mellitus.